微手术治疗的ethmoidal 长期动脉静脉囊
David R Hallan1, Jinpyo Hong1, Ephraim W Church1
1Department of Neurosurgery, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
World neurosurgery
|February 7, 2026
概括
乙状持续性动脉静脉 (dAVFs) 是罕见的,可以导致严重的神经缺陷. 微手术提供了一种有效的初级治疗选择,最大限度地降低了与其他干预相关的风险.
科学领域:
- 神经外科 神经外科
- 血管神经学 血管神经学
- 干预性放射学 干预性放射学
背景情况:
- 乙状持续性动脉静脉 (dAVFs) 是一种罕见的内血管病变,占所有dAVFs的2-3%.
- 这些囊通常由眼动脉的ethmoidal分支提供,如果通过内血管治疗,可能会导致失明的风险.
- 高度的dAVFs与皮质静脉排水或症状需要干预由于内高血压或出血的风险.
研究的目的:
- 为了证明微手术技术为ethmoidal dAVF断开连接.
- 突出了开放式手术的有效性作为一种主要的治疗 ethmoidal dAVFs.
- 为了说明这一罕见疾病的关键解剖学标志和手术步骤.
主要方法:
- 一名78岁的男性患有困惑经历了诊断性脑血管造影,显示出一种ethmoidal dAVF.
- 进行了微手术切断,包括下关节切割,识别食动脉和排水静脉,以及断裂.
- 手术后的管理包括对并发症的监测和后续成像.
主要成果:
- 患者经历了手术后完全消除混乱的经历.
- 最初的康复非常出色,只有轻微的湿瘤并发症需要排水.
- 1个月和1年后的随访成像证实没有残留的囊或复发,患者神经系统完好无损.
结论:
- 微手术是一种有效的初级治疗 ethmoidal dAVFs,成功治疗,同时减轻视觉妥协的风险.
- 描述的手术策略允许安全有效地切断这些复杂的血管病变.
- 开放式手术为内血管方法提供了可行的替代方案,特别是当视觉通路面临风险时.
相关概念视频
01:27Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:22Alzheimer's Disease: Treatment
968
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
01:26Anticholinesterase Agents: Poisoning and Treatment
1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K
01:28Angle Closure Glaucoma: Treatment
1.3K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K